Committee to 'watch' bill on hospitals dispensing unused portions of drugs to ER patients after detailed debate

The Legislation and Regulation Committee discussed Assembly Bill 447, which would allow a prescriber to dispense an unused portion of a dangerous drug acquired from a hospital pharmacy to an emergency room patient under specified conditions, but the committee took no formal position and elected to "watch" the measure for further amendments.

Members and public commenters agreed the bill aims to improve patient access to medications after an emergency visit, but debated specific risks including labeling, documentation and whether automated drug dispensing systems (ADDS) used in hospitals should be exempt from licensure when dispensing to outpatients.

Committee chair Jessica Crowley opened the agenda item by summarizing the bill and staff recommendation to "watch," noting the measure had recently passed committee with further amendments not yet in print.

Licensee member Maria Serpa, who described long experience in acute-care pharmacy, said the issue "is real" and described common scenarios — inhalers, creams and ointments — where patients leave the emergency department needing a usable dose. She cautioned, however, that "the concern comes with having it be appropriately labeled and having all the information that the patient needs and that it be documented that it was dispensed to the patient by the pharmacy." Serpa said emergency-room medications remain "in the pharmacy's inventory" and described prior discussions around controlled-substance supplies and prescriber dispensing in ER settings.

Licensee member Nicole Thiebaud said the measure could improve time-sensitive access to postexposure prophylaxis (PEP) for HIV and other urgent therapies, asking whether the bill would permit dispensing a full bottle required for a course of therapy. "That would be something I'd be interested in learning as we go through this process," she said.

Public commenters and stakeholders largely urged preserving labeling and documentation standards and supported narrow exemptions for ADDS where appropriate. Keith Yoshizuka of the California Society of Health System Pharmacists urged amendments or clarifying language to ensure labeling requirements remain clear and not to create a loophole where medications are handed to patients without adequate labels. Michelle Rivas of the California Pharmacists Association said CPHA supported the concept "if amended" and asked the committee to ensure pharmacists dispensing remain held to "the same vigorous standards" as other dispensing. Andre Peters, a pharmacist speaking in a personal capacity, urged exempting certain ADDS from licensure if the purpose is limited to providing stock for on-site use rather than creating new outpatient dispensaries.

Speakers repeatedly flagged risk of "scope creep" — for example, a prescriber dispensing an entire course of tablets from an ADDS rather than a single used portion — and urged clearer definitions of "unused portion" to avoid turning ADDS into de facto outpatient dispensaries. Stakeholders described existing hospital relabeling workflows and the potential for delays if relabeling is required before dispensing to patients going home.

After public comment, the committee did not move a formal motion to take a position; the item was recorded as "watch." Committee members said staff should continue to monitor amendments and report back at a future meeting so that the board can consider a formal position once bill language stabilizes.

The committee did not adopt substantive text changes or votes on this measure during the April 9 meeting.